Charcot-Marie-Tooth Neuropathy Axonal Type 2O

Charcot-Marie-Tooth neuropathy axonal type 2O (often shortened to CMT2O) is a rare inherited nerve disease that mainly affects the long nerves to the legs and arms. It belongs to the “axonal” group of Charcot-Marie-Tooth diseases, which means the main problem is damage to the long fibre (axon) of the nerve, not the myelin covering. People with CMT2O usually develop slowly worsening weakness and thinning of the muscles in the feet and lower legs, and later in the hands. MalaCards+1

Charcot-Marie-Tooth neuropathy axonal type 2O (CMT2O) is a very rare genetic nerve disease where the long wires of the nerves (axons) slowly become damaged, especially in the legs and feet, and later in the hands. It is usually caused by a harmful change in a gene called DYNC1H1, which helps move important materials up and down the nerve cell. When this transport system fails, the nerve endings weaken and die back, so muscles get less signals, leading to weakness, thin muscles, high-arched feet (pes cavus), and problems with balance and walking. CMT2O is generally inherited in an autosomal dominant way, which means one changed copy of the gene is enough to cause disease, and symptoms often start in childhood and slowly get worse over life. There is no current cure, but many supportive therapies, medicines, and lifestyle changes can reduce symptoms and improve daily function and quality of life. MDPI+4MalaCards+4NCBI+4

CMT2O is caused by a change (mutation) in a gene called DYNC1H1, which sits on chromosome 14. This gene makes part of a motor protein called cytoplasmic dynein, which works like a tiny motor carrying cargo along the nerve cell’s internal “railway”. When the gene is faulty, the nerve cannot move nutrients and cell parts along its long axon properly, so the axon slowly becomes sick and dies back, especially in the far-away parts in the feet and hands. MalaCards+1

CMT2O usually follows an autosomal dominant pattern. This means a person can get the condition if they inherit one faulty copy of the DYNC1H1 gene from either parent. Sometimes, the gene change happens for the first time in the child (a “de novo” mutation), so there is no past family history, even though the condition is genetic. MalaCards+1

Other names

Doctors and researchers use several different names for this same condition. All of the names below refer to the same basic disorder:

• Charcot-Marie-Tooth disease, axonal, type 2O

• CMT2O

• Charcot-Marie-Tooth neuropathy axonal type 2O

• Autosomal dominant axonal Charcot-Marie-Tooth disease type 2O

• Charcot-Marie-Tooth disease caused by mutation in DYNC1H1

• DYNC1H1-related Charcot-Marie-Tooth disease type 2O

These different names can be confusing, but they all point to an axonal CMT that is linked to DYNC1H1 gene mutations and inherited in a dominant way. MalaCards+2National Organization for Rare Disorders+2

Types

CMT2O itself is one specific subtype within the larger CMT type 2 (axonal) group. However, doctors may still describe “types” or “patterns” inside CMT2O to help understand the course of the illness: cmtausa.org+1

• By age of onset

  • Early-childhood onset: many patients show walking delay, clumsy gait, or frequent falls in the first years of life. orpha.net

  • Later-childhood or adult onset: in some people, weakness appears later, with fewer developmental problems.

• By severity

  • Mild form: slight foot deformity, mild weakness, near-normal walking as an adult.

  • Moderate form: clear weakness in feet and hands, difficulty running, frequent trips and falls.

  • Severe form: marked contractures, scoliosis, and difficulties with walking long distances or fine hand tasks.

• By extra nervous-system features

  • Pure peripheral neuropathy: only nerves to limbs are affected.

  • Complex form: some people also have delayed speech, learning difficulties, spasticity, or seizures because DYNC1H1 can also affect brain development. MalaCards+2ScienceDirect+2

These “types” are not official separate diseases but are helpful descriptions of how the same gene problem can appear differently in different people.

Causes

CMT2O has one main cause – a mutation in the DYNC1H1 gene. The 20 items below describe different aspects and related factors that explain how and why this gene change leads to disease or makes it worse. MalaCards+1

1. Heterozygous DYNC1H1 mutation
   The core cause is a single faulty copy of the DYNC1H1 gene (heterozygous mutation). This change alters the structure of the dynein motor protein. The damaged motor cannot move cargo properly along the nerve axon, so the axon slowly degenerates, especially in the longest nerves to the feet. MalaCards+1

2. Autosomal dominant inheritance
   Because the condition is dominant, one affected parent has a 50% chance of passing the faulty gene to each child. A strong family history of similar foot problems and walking difficulties is therefore a major cause and clue for CMT2O in many families. MalaCards+1

3. De novo DYNC1H1 variants
   In some patients, the mutation appears freshly in the egg or sperm or very early after conception. These de novo changes cause disease even when both parents are unaffected, and they explain cases with no known family history. MalaCards+1

4. Missense mutations in the motor domain
   Many disease-causing changes are “missense” mutations in the motor head of dynein, the part that walks along microtubule tracks. When this region is altered, the motor cannot generate enough force or steps, leading to defective axonal transport and nerve fibre loss. MalaCards+1

5. Mutations in the tail or cargo-binding region
   Some variants affect the tail part of DYNC1H1, which binds cargo proteins and organelles. When cargo cannot attach properly to dynein, essential materials do not reach the far ends of the axons, which causes axonal stress and degeneration. MalaCards+1

6. Disrupted transport of mitochondria
   Dynein mutations disturb the movement of mitochondria, the “energy factories” of the nerve cell. Without enough mitochondria in the distal axon, local energy supply drops, and the nerve ending becomes weak and vulnerable to damage. ScienceDirect+1

7. Impaired transport of growth factors and vesicles
   Dynein also carries growth factors, signalling molecules, and small vesicles along the axon. When this transport is impaired, survival signals from muscles and skin do not reach the nerve cell body efficiently, promoting slow dying-back of the axon. ScienceDirect+1

8. Selective vulnerability of long peripheral nerves
   The longest nerves to the feet and lower legs are most affected because they require the longest and most demanding axonal transport. This length-dependent vulnerability explains why symptoms usually start in the feet and later spread to the hands. Europe PMC+1

9. Developmental effects on motor neurons
   Some DYNC1H1 variants disturb brain and spinal cord development. This can cause motor delay, abnormal gait, and sometimes spasticity or intellectual disability, adding central nervous system problems on top of the peripheral neuropathy. MalaCards+1

10. Genetic background and modifier genes
    Other genes involved in nerve structure and repair can modify how strongly a DYNC1H1 mutation shows itself. In some families the same mutation causes severe symptoms, while in others it is milder, likely because of different background genes. MDPI+1

11. Coexisting neuropathy causes (e.g., diabetes)
    Conditions like diabetes, vitamin B12 deficiency, or alcohol-related neuropathy can damage axons further. When these occur in someone who already has CMT2O, they can make symptoms appear earlier or more severe, even though they are not the root genetic cause. Europe PMC

12. Mechanical stress on weak muscles and nerves
    High arches, hammertoes, and ankle instability can put strain on nerves and tendons. Over years, repeated minor strains may worsen pain and weakness in a person whose nerves are already fragile from CMT2O. NCBI+1

13. Lack of physical conditioning
    If weak muscles are rarely used, they become even weaker and smaller. While this does not cause the genetic problem, low activity can speed up loss of function in already compromised limbs.

14. Under-treated joint deformities
    Foot and ankle deformities that are not supported with braces, shoes, or surgery can lead to repeated sprains, falls, and joint damage. This extra stress contributes to disability in CMT2O over time. cmtausa.org+1

15. Spinal deformities such as scoliosis
    Some people with DYNC1H1 mutations develop scoliosis. Abnormal spine curves can stretch or compress nerve roots, adding extra nerve stress and worsening leg weakness and pain. MalaCards+1

16. Growth spurts in childhood
    When a child grows quickly, the nerve axons have to extend and keep up. In a child with CMT2O, this can unmask symptoms like tripping or falls because the already weak axonal transport is stressed by rapid growth. orpha.net+1

17. Infections or inflammation affecting nerves
    Severe viral infections or immune-mediated nerve inflammation can overlap with hereditary neuropathy. These do not cause CMT2O but may temporarily worsen weakness or sensation in someone with the disease.

18. Medications that are toxic to nerves
    Some chemotherapy drugs and a few other medicines are known to damage peripheral nerves. Doctors try to avoid such drugs or use them with great care in people who have CMT, because they can trigger sudden worsening on top of the inherited neuropathy. Europe PMC

19. Age-related axonal loss
    Normal ageing causes some loss of nerve fibres. In CMT2O, this natural decline adds to the genetic axonal damage, so older adults can notice slower walking, more imbalance, and more fatigue than in earlier life. Europe PMC+1

20. Unknown or still-unclassified DYNC1H1 variants
    New DYNC1H1 mutations continue to be found, and researchers are still learning which ones clearly cause CMT2O and how they act. For some families, the exact biological effect of their specific variant remains under study. MalaCards+1

Symptoms

Symptoms in CMT2O usually start in childhood with problems in the feet and legs and slowly progress. Not everyone has every symptom, but many people share the features below. NCBI+2MalaCards+2

1. Distal lower-limb weakness
   Weakness starts in the muscles around the ankles and feet. Children may struggle to stand on their toes or heels, and adults may find it hard to walk on uneven ground because the small lower-leg muscles cannot lift or control the foot well.

2. Foot drop
   Foot drop means the front of the foot does not lift properly when walking. The person may catch their toes on the ground and stumble. They often lift their knees higher in a “steppage gait” to avoid tripping. NCBI+1

3. Pes cavus (high-arched feet)
   Many patients develop high-arched, stiff feet with curled toes. The shape of the foot changes because the balance between weak and strong muscles is uneven, pulling the bones into an abnormal position over years. NCBI+1

4. Frequent falls and tripping
   Because of weakness, foot drop, and poor balance, children and adults may trip often, especially on stairs or rough ground. Falls can lead to injuries and fear of walking outdoors. NCBI+1

5. Difficulty running and jumping
   Running needs fast, strong ankle and hip muscles. In CMT2O, patients often cannot run as fast as classmates in school or may stop running sports early because their legs feel heavy and unstable. cmtausa.org+1

6. Distal muscle wasting (atrophy)
   Over time, the muscles below the knees and later in the hands may become noticeably thinner. The legs can look like an “inverted champagne bottle” – thin below the knee and fuller above. MalaCards+1

7. Hand weakness and fine-motor problems
   In later stages, weakness can also affect the small muscles of the hands. People may struggle to button clothes, write for long periods, or open jars. The fingers may look bony because of muscle loss. MalaCards+1

8. Distal sensory loss (numbness or reduced feeling)
   Sensation in the feet and toes often becomes dull. Patients may not feel light touch, vibration, or pinprick as well. This can make it harder to notice small injuries or how firmly the foot is pressing on the ground. NCBI+1

9. Tingling, burning, or neuropathic pain
   Some people feel abnormal sensations like tingling, pins-and-needles, burning, or electric shocks in their feet and hands. These sensations come from irritated or damaged nerve fibres. Europe PMC

10. Reduced or absent reflexes (hyporeflexia)
    When a doctor taps the knee or ankle with a reflex hammer, the usual response may be weak or absent. This happens because the reflex arc needs healthy sensory and motor axons, which are affected in CMT2O. NCBI+1

11. Abnormal gait and poor balance
    People often walk with a steppage gait, lifting their legs high and slapping the feet down. Balance can be poor, especially in the dark or when standing with feet together, because the brain receives less sensation from the feet. Europe PMC+1

12. Motor developmental delay in childhood
    Some children sit, stand, or walk later than usual. They may be slower at jumping, hopping, or climbing stairs. Parents may first notice that their child is “clumsy” compared to siblings or classmates. orpha.net+1

13. Global developmental delay or learning difficulties (in some cases)
    Because DYNC1H1 also plays a role in brain development, some children with certain mutations have learning difficulties, delayed speech and language, or intellectual disability along with neuropathy. NCBI+2MalaCards+2

14. Joint contractures and arthrogryposis
    When weak muscles cannot move joints through their full range over many years, the joints may become stiff and fixed (contractures). Some babies may even be born with stiff joints (arthrogryposis) due to decreased movement in the womb. MalaCards+1

15. Scoliosis and sometimes spasticity
    Some patients develop a sideways curve of the spine (scoliosis) or increased muscle tone and stiffness (spasticity), especially when central nervous system features are present. These signs show that the gene change can affect both peripheral and central motor pathways. MalaCards+1

Diagnostic tests

Doctors use a mix of clinical examination, electrical tests, genetic tests, and imaging to diagnose CMT2O and to rule out other causes of neuropathy.

Physical exam tests

1. Detailed medical and family history
   The doctor asks about age of onset, walking and running problems, falls, and hand weakness. They also ask if other family members have similar foot deformities or walking issues. A clear pattern of slowly progressive symptoms with a dominant family tree strongly suggests CMT2O or another inherited neuropathy. orpha.net+1

2. Inspection of feet, legs, and spine
   The doctor looks for pes cavus, hammertoes, thin calf muscles, and spinal curves. These visible changes are classic in CMT and support the diagnosis, especially when both legs are affected in a similar way. NCBI+1

3. Muscle strength examination
   Strength is tested using simple resistance, usually graded on the Medical Research Council (MRC) scale from 0 to 5. Weakness is typically worst in ankle dorsiflexion (lifting the foot), toe extension, and later in intrinsic hand muscles, matching a length-dependent axonal neuropathy. Europe PMC+1

4. Sensory examination
   The doctor checks light touch, pinprick, vibration (with a tuning fork), and position sense in the toes and fingers. In CMT2O, the loss is usually mild to moderate and more noticeable in the feet, with a “stocking” pattern. NCBI+1

5. Reflex testing and gait assessment
   Reflexes at the knees and ankles are tested with a hammer. Reduced ankle reflexes are common. The doctor also watches the person walk on heels, toes, and in a straight line, looking for steppage gait and balance problems. Europe PMC+1

Manual functional tests

6. Manual muscle testing of lower limbs
   The clinician manually resists movements at the ankles, knees, and hips to see which muscle groups are weak. Detailed grading helps track disease progression and plan physiotherapy and bracing.

7. Manual muscle testing of upper limbs and hands
   Grip strength and pinch between thumb and fingers are tested. Weakness in small hand muscles suggests the neuropathy has progressed proximally along the nerves to the upper limbs. Europe PMC

8. Range-of-motion and joint flexibility testing
   Using simple physical manoeuvres (and sometimes a goniometer), the clinician measures how far the ankles, knees, and spine can move. Limited movement shows contractures or scoliosis, which may need orthopaedic treatment. orpha.net

9. Timed functional walking tests
   Simple tests such as the 10-metre walk test or 6-minute walk test measure how fast and how far a person can walk safely. These tests give a practical picture of daily walking ability and help follow changes over time or after treatment such as bracing or surgery. MDPI

Lab and pathological tests

10. Basic blood tests to exclude other neuropathies
    Blood tests for glucose, vitamin B12, thyroid function, kidney and liver function, and some antibodies help rule out common acquired neuropathy causes like diabetes or vitamin deficiency. Normal results support the idea of a hereditary neuropathy such as CMT2O. Europe PMC

11. Targeted DYNC1H1 genetic testing
    If the clinical picture suggests CMT2O or another DYNC1H1-related disorder, the lab can sequence the DYNC1H1 gene directly. Finding a known disease-causing variant confirms the diagnosis and allows accurate genetic counselling. MalaCards+1

12. Comprehensive CMT or neuropathy gene panel
    In many centres, doctors order a next-generation sequencing panel that tests many neuropathy genes at once, including DYNC1H1. This is helpful because different CMT subtypes can look very similar from symptoms alone. MalaCards+1

13. Nerve biopsy (now rarely needed)
    In older practice, a small piece of peripheral nerve was removed and examined under the microscope. In axonal CMT, the biopsy shows axonal loss with relatively preserved myelin. Today, genetic testing has largely replaced biopsy, so this test is reserved for unclear or complex cases. Europe PMC

Electrodiagnostic tests

14. Nerve conduction studies (NCS)
    NCS measure how fast and how strongly electrical signals travel along the nerves. In CMT2O, conduction velocities are usually normal or only slightly slow, but the response sizes (amplitudes) are reduced, showing loss of axons rather than myelin damage. MalaCards+1

15. Electromyography (EMG)
    EMG uses a fine needle electrode in muscles to record electrical activity. In axonal neuropathy, EMG may show signs of chronic denervation and re-innervation, such as large motor units, confirming long-standing nerve fibre loss. Europe PMC+1

16. Late response studies (F-waves and H-reflexes)
    These tests look at signal travel along the whole motor pathway. In CMT2O, some late responses can be reduced or absent because many axons are lost, adding further proof of a diffuse peripheral neuropathy.

17. Advanced electrodiagnostic protocols
    In research or complex cases, doctors may use more detailed nerve tests to distinguish between different CMT subtypes or to study how severely different nerves are affected. These studies are especially useful in new DYNC1H1 variant reports. ScienceDirect+1

Imaging tests

18. X-ray of feet and spine
    Simple X-rays can show the degree of pes cavus, hammertoes, ankle instability, and scoliosis. This helps orthopaedic surgeons plan braces or corrective surgery to improve walking and reduce pain. cmtausa.org+1

19. MRI of brain and spinal cord (when needed)
    If a patient has seizures, spasticity, or marked developmental delay, doctors may order MRI of the brain and spinal cord to look for structural changes or other causes. In some DYNC1H1-related disorders, MRI can show abnormalities in brain structure. MalaCards+1

20. MRI neurography or nerve ultrasound
    Special imaging of the peripheral nerves can sometimes be used to show nerve size and shape. In axonal CMT, nerves may be normal or only mildly enlarged, which helps distinguish it from some demyelinating neuropathies where nerves are more obviously swollen. ScienceDirect+1

Non-Pharmacological Treatments

1. Regular physical therapy (physiotherapy)
Physical therapy is one of the main treatments for CMT2O. A trained physiotherapist designs gentle, low-impact exercises (stretching, strengthening, balance work, walking training) to keep muscles active and joints flexible. This helps slow muscle shortening (contractures), reduce stiffness, and maintain walking ability. Early and regular therapy can delay disability and help people stay independent longer, even though it cannot cure the genetic problem. Mayo Clinic+2nhs.uk+2

2. Occupational therapy (OT)
Occupational therapists focus on the “skills of daily life” such as dressing, cooking, writing, and using phones or computers. They can suggest special tools like built-up pen grips, Velcro clothing instead of buttons, and adapted kitchen equipment. This therapy reduces fatigue and frustration by making daily activities simpler and safer, which is very important when hands are weak or clumsy. Muscular Dystrophy Association+2CoxHealth+2

3. Ankle-foot orthoses (AFOs)
AFOs are light plastic or carbon-fiber braces worn inside the shoe and around the lower leg. They hold the ankle in a safe position so the toes do not drop, reducing tripping and falls. For CMT2O, where foot drop and weak ankle muscles are common, AFOs can dramatically improve walking pattern, stability, and confidence, and may slow joint deformity by keeping joints in better alignment. PMC+2nhs.uk+2

4. Custom shoes and insoles
Custom orthopaedic shoes and insoles support high-arched or twisted feet and redistribute pressure away from painful areas. For CMT2O, these devices can reduce pain from abnormal foot shape, improve balance, and prevent skin breakdown or ulcers. Shoe adaptations may include wider toe boxes, extra depth, and firm heel counters to help control ankle position during walking. PMC+2nhs.uk+2

5. Hand splints and wrist supports
Hand splints, thumb spicas, and wrist supports hold weak joints in a functional position to improve grip and protect from over-stretching. OT or hand therapists decide which splint is best. In CMT, splints can improve fine motor tasks like writing, using utensils, and typing, and may prevent joint deformities in fingers and wrists over time. cmtausa.org+1

6. Balance and gait training
Because CMT2O causes weakness and sensory loss in the feet, balance can be poor, and falls are common. Therapists use balance boards, parallel bars, and targeted exercises to retrain how the body responds to uneven ground. This training teaches safer walking strategies, improves confidence, and can reduce the risk of fractures or injuries from falls. PMC+2Journal of Health and Allied Sciences NU+2

7. Stretching and range-of-motion exercises
Daily stretching of calves, hamstrings, and foot muscles helps keep joints flexible and reduces painful stiffness. In CMT2O, where muscles slowly weaken and tendons can tighten, stretching is crucial to prevent fixed deformities like ankle contractures or curled toes. Therapists teach safe home programs so patients and families can continue stretching long-term. nhs.uk+2PMC+2

8. Strength training with low resistance
Gentle strengthening of remaining healthy muscles can support weak areas and improve function. In CMT, high-load, high-impact training can damage fragile nerves and muscles, so low-resistance, high-repetition programs are recommended. This helps maintain endurance, improve walking distance, and support posture, without over-stressing already damaged nerves. PMC+2MDPI+2

9. Aquatic (water-based) therapy
Water supports body weight, so exercise in a warm pool lets people with CMT2O move more easily and safely. Gentle walking, kicking, and balance tasks in water reduce joint stress, help pain, and build cardiovascular fitness. This can be especially helpful when land-based exercises are too painful or tiring. nhs.uk+2PMC+2

10. Pain psychology / cognitive-behavioral therapy (CBT)
Living with chronic nerve pain, weakness, and disability can cause anxiety and low mood. Pain psychologists teach coping skills, relaxation, pacing, and thought-reframing. CBT does not remove nerve damage, but it can reduce suffering, improve sleep, and help people stay engaged with their life plan and therapies. PMC+1

11. Assistive devices for mobility (canes, walkers, wheelchairs)
Some people with CMT2O eventually need walking aids to move safely and conserve energy. A cane or walker can provide extra support and reduce the risk of falls; for long distances, a wheelchair or scooter may be needed. Using these devices is not “giving up” – it is a strategy to stay mobile and independent in daily life. Muscular Dystrophy Association+2PMC+2

12. Home safety modifications
Simple changes at home—grab bars in the bathroom, non-slip mats, good lighting, removing loose rugs, and using ramps instead of stairs—greatly reduce fall risk. For CMT2O, where balance and foot control are poor, these modifications help prevent serious injuries and make it easier to move around with braces or walking aids. PMC+1

13. Energy conservation and pacing education
Fatigue is common in people with neuromuscular disease. Therapists teach pacing (taking breaks before exhaustion), planning tasks, and prioritizing important activities. Learning to balance activity and rest helps people with CMT2O avoid over-use of weak muscles, minimize pain flares, and remain active over the whole day instead of burning out early. PMC+1

14. Genetic counseling for the family
Because CMT2O is usually autosomal dominant, there is a 50% chance of passing the gene change to children. Genetic counselors explain inheritance, testing options, and family planning choices in simple language. This does not change the current disease, but it helps families make informed decisions and reduces anxiety about the future. MalaCards+2NCBI+2

15. Vocational rehabilitation and school accommodations
Specialists can help adjust work tasks or school activities to match physical limits, for example with ergonomic keyboards, speech-to-text software, or extra time for exams. This support allows people with CMT2O to stay in education or employment and reduces stress caused by trying to meet normal physical demands. PMC+1

16. Psychological counseling and peer support groups
Talking with a counselor or joining CMT support groups lets people share experiences and emotions. Feeling understood and supported can decrease depression and isolation, and peer advice can make it easier to manage daily challenges like shoe choice, brace use, or fatigue. Muscular Dystrophy Association+1

17. Respiratory and sleep assessment (if needed)
Although most CMT2O patients mainly have limb problems, some neuromuscular disorders can affect breathing or cause sleep apnea. A sleep or lung specialist may perform tests if there is snoring, daytime sleepiness, or morning headaches. Managing breathing or sleep issues can improve energy, thinking, and overall quality of life. PMC+1

18. Nutritional counseling for nerve health
Dietitians can help maintain healthy weight and ensure good intake of vitamins and minerals important for nerve and muscle function, such as B-vitamins, vitamin D, and antioxidants. While diet cannot fix the gene mutation, it can support general health, bone strength, and energy, which indirectly improves function in CMT2O. MDPI+1

19. Avoiding nerve-toxic medications and toxins
Certain chemotherapy drugs and some other medicines can worsen peripheral neuropathy. Doctors try to avoid or carefully monitor these in people with CMT. Informing every new doctor about the diagnosis of CMT2O helps them choose safer medications and lower the risk of sudden worsening of nerve damage. PMC+1

20. Participation in clinical research (where available)
There are no approved disease-modifying treatments yet, but researchers are studying gene therapies, neuroprotective drugs, and other options for CMT. Carefully designed clinical trials give some patients access to experimental treatments under strict monitoring and help discover better therapies for the future. Participation is voluntary and must be discussed with doctors and the study team. MDPI+2ScienceDirect+2

---

Drug Treatments

Important safety note: Many of these medicines are prescription-only and can cause serious side effects. Typical doses mentioned are from FDA labels for other neuropathic pain conditions, not specific instructions for CMT2O. A neurologist or pain specialist must decide if they are right for a particular person, especially for anyone under 18.

1. Gabapentin
Gabapentin is an anti-seizure drug widely used to treat neuropathic pain. FDA labels show adult doses often titrated up from 300 mg per day to 1,800–3,600 mg per day in divided doses for conditions like post-herpetic neuralgia. It calms over-active nerve firing by binding to calcium channels, which can reduce burning or shooting pain in CMT2O, but may cause dizziness, sleepiness, and weight gain. FDA Access Data+2FDA Access Data+2

2. Pregabalin
Pregabalin is similar to gabapentin but more potent and is approved for several neuropathic pain conditions. Typical adult doses in labels range from 150–600 mg per day in divided doses, adjusted for kidney function. It reduces abnormal pain signals by acting on calcium channels in the central nervous system and can improve nerve pain and sleep, but side effects include dizziness, swelling of legs, and weight gain. FDA Access Data+2FDA Access Data+2

3. Duloxetine
Duloxetine is an antidepressant (SNRI) that is FDA-approved for diabetic peripheral neuropathic pain at 60 mg once daily. It works by increasing serotonin and norepinephrine in pain pathways, which can reduce chronic nerve pain and improve mood. In people with CMT-related pain, doctors sometimes use similar doses, but nausea, dry mouth, and sleep changes can occur, and it must be used carefully in young people. FDA Access Data+2FDA Access Data+2

4. Amitriptyline
Amitriptyline is a tricyclic antidepressant often used at low doses for chronic neuropathic pain, especially at night. Labels list many dose strengths (10–150 mg tablets) and highlight its effects on norepinephrine and serotonin re-uptake. In practice, doctors start with low doses (for example 10–25 mg at bedtime in adults) and increase slowly. It can improve pain and sleep but may cause dry mouth, constipation, weight gain, and, rarely, heart rhythm problems. FDA Access Data+2FDA Access Data+2

5. Nortriptyline
Nortriptyline is related to amitriptyline but may cause slightly fewer sedating or anticholinergic side effects. It is also used off-label for nerve pain at low doses, usually at night, to improve sleep and reduce burning sensations. Its mechanism is similar—blocking norepinephrine re-uptake—which modulates pain pathways in the spinal cord and brain. Side effects can include dry mouth, dizziness, and heart rhythm changes, so cardiac history must be checked. PMC+1

6. Tramadol
Tramadol is a centrally acting pain medicine with both weak opioid activity and serotonin/norepinephrine re-uptake inhibition. FDA labels warn about serious risks, especially in children, including life-threatening breathing problems and dependence. Doses in adults are typically limited and carefully adjusted. In some adults with severe CMT-related pain, specialists may use tramadol when other neuropathic medicines are not enough, but it must be used very cautiously and never started without close medical supervision. FDA Access Data+2FDA Access Data+2

7. Topical lidocaine 5% patch
Lidocaine patches (such as LIDODERM) deliver local anesthetic through the skin. They are FDA-approved for post-herpetic neuralgia, where up to three patches can be applied to painful areas for up to 12 hours in adults. For focal nerve pain in CMT2O—for example on the top of the foot—some doctors use similar patches to numb the area, with fewer whole-body side effects than oral drugs. FDA Access Data+2FDA Access Data+2

8. Capsaicin 8% patch
High-strength capsaicin (Qutenza) patches are applied in clinic under supervision for localized neuropathic pain. Capsaicin overstimulates and then “desensitizes” certain pain fibers (TRPV1 receptors), which can reduce pain for weeks or months after a single application. FDA labels describe it for post-herpetic neuralgia and diabetic neuropathy, and it can cause intense burning during treatment, so local anesthesia and careful protection of eyes and mucous membranes are needed. FDA Access Data+2FDA Access Data+2

9. Baclofen
Baclofen is a muscle relaxant that acts on GABA receptors in the spinal cord to reduce muscle spasms and stiffness. It is indicated for spasticity in conditions like multiple sclerosis, with adult doses titrated up carefully (for example to 80 mg/day in some labels). In CMT2O, baclofen may be used if there are troublesome cramps or spasticity-like features, but sudden withdrawal can be dangerous, so doses must be changed slowly under medical guidance. FDA Access Data+2FDA Access Data+2

10. Non-steroidal anti-inflammatory drugs (NSAIDs)
Medicines like ibuprofen and naproxen are not specific for nerve pain but can help with musculoskeletal pain from joint strain, deformities, or over-worked muscles. They work by blocking COX enzymes that produce inflammatory prostaglandins. Because long-term use can irritate the stomach and affect kidneys or heart, they should be used at the lowest effective dose and under a doctor’s advice, especially when used frequently. PMC+1

11. Acetaminophen (paracetamol)
Acetaminophen is a common over-the-counter pain reliever used for mild pain and fever. It does not directly treat nerve pain but can reduce background aches and make other therapies more effective. It is generally safer for the stomach than NSAIDs, but high doses can damage the liver, so total daily dose limits must be followed carefully. PMC+1

12. Botulinum toxin injections
Botulinum toxin can be injected into specific overactive muscles to reduce tightness or abnormal postures. In some neuromuscular and spasticity conditions, it helps correct foot or ankle positioning and reduces pain. Its effect is temporary (about 3–4 months), and dosing must be done by experienced specialists using anatomical guidance or ultrasound. PMC+1

13. Low-dose benzodiazepines (for severe muscle cramps – used cautiously)
In select adults, short-acting benzodiazepines may be used at low dose for severe nocturnal cramps not relieved by other medicines. They act on GABA receptors and relax muscles, but they carry risks of dependence, sedation, and falls, and are not generally appropriate for children or long-term use. Any use must be carefully evaluated by a specialist. PMC+1

14. Antidepressants (SSRIs/SNRIs) for mood and pain modulation
Beyond duloxetine, other antidepressants may be used to treat depression and anxiety linked to chronic disease, and some also have modest effects on pain perception. By improving mood and sleep, they can indirectly ease the experience of neuropathic pain. Choice of drug depends on age, other medical problems, and potential side effects like weight change or sexual dysfunction. PMC+1

15. Sleep aids (used short-term, if necessary)
Bad nerve pain can disrupt sleep, which then worsens pain perception and fatigue. Sometimes doctors prescribe short courses of sleep-supporting medicines, or optimize pain medicines at night, to restore sleep cycles. Good sleep hygiene (dark, quiet room, routine bedtime) is preferred, and medicines are used only when benefits clearly outweigh risks. PMC+1

16. Anti-cramp agents (such as mexiletine – specialist use)
For some inherited neuromuscular conditions with severe muscle cramps, sodium-channel blockers such as mexiletine may be considered by neuromuscular experts. They alter how sodium channels in muscle cells fire, reducing repetitive discharges that cause cramps. Because of cardiac and other risks, these medicines are only used under strict specialist supervision, often guided by clinical trial data. PMC+1

17. Vitamin D and calcium supplements (if deficient)
While not classic “drugs”, correcting vitamin D or calcium deficiency is important for bone health, especially if mobility is reduced. Adequate levels lower the risk of fractures from falls and support muscle function. Doses are based on blood tests and age; too much vitamin D can cause high calcium, so supplementation must follow medical advice. MDPI+1

18. Anti-spastic agents via intrathecal pumps (very selected cases)
In rare situations with severe spasticity and pain not controlled by oral medicine, continuous intrathecal baclofen (through a pump) may be considered. This delivers small amounts of medicine directly into spinal fluid, giving strong effect with lower systemic doses. It requires surgery and ongoing follow-up, so it is reserved for carefully chosen cases. PMC+1

19. Short courses of oral steroids (only if there is another inflammatory problem)
CMT2O itself is not an inflammatory disease, so routine steroids are not used. However, if a person with CMT2O also develops an inflammatory neuropathy or another autoimmune disease, doctors may use steroids briefly. Steroids reduce immune activity but have many side effects, such as weight gain, diabetes, and bone loss, so they must be used cautiously. PMC+1

20. Emerging gene-targeted or neuroprotective drugs (research stage)
Experimental drugs that aim to protect axons or correct gene defects are being studied for various forms of CMT. These include small molecules, antisense oligonucleotides, and other targeted agents. For CMT2O specifically, treatment is still at research or model stage, and there are no approved disease-modifying drugs yet; any use would only be in a formal clinical trial. MDPI+2ScienceDirect+2

---

Dietary Molecular Supplements

Important: Evidence for supplements in CMT2O is limited. Most data come from other neuropathies. Always discuss supplements with a doctor, especially if you take other medicines.

1. B-complex vitamins (B1, B6, B12)
B-vitamins are essential for nerve metabolism and myelin health. In people with deficiencies, replacing B1, B6, or B12 can improve neuropathy symptoms. Typical doses vary by product (for example, B12 500–1,000 µg/day in deficiency under medical guidance). In CMT2O, supplements will not fix the genetic mutation but may support general nerve health if blood levels are low. MDPI+1

2. Alpha-lipoic acid
Alpha-lipoic acid is an antioxidant used in some countries for diabetic neuropathy, often at oral doses like 600 mg/day in adults in studies. It helps reduce oxidative stress in nerves and may modestly improve pain or tingling. For CMT2O, evidence is indirect, but some clinicians consider it as an adjunct, watching for side effects like nausea or low blood sugar. MDPI+1

3. Omega-3 fatty acids (fish oil)
Omega-3 fats help build cell membranes and have anti-inflammatory effects. Regular intake through oily fish or supplements may support heart and nerve health. Doses used for general health vary (for example 1–3 g EPA/DHA per day in adults in some studies). They can thin the blood slightly, so people on anticoagulants need medical advice before use. MDPI+1

4. Coenzyme Q10 (CoQ10)
CoQ10 supports mitochondrial energy production. In some neuromuscular and mitochondrial disorders, supplementation has shown small functional benefits. Usually, doses of 100–300 mg/day are used in adults in studies. In CMT2O, evidence is limited, but CoQ10 may help support muscle energy and reduce fatigue, with side effects like stomach upset in some people. MDPI+1

5. Vitamin D
Vitamin D is important for bone strength, immune function, and muscle performance. Low vitamin D is common in people with low mobility. Supplementation (dose based on blood levels and age) reduces fracture risk and may slightly improve muscle performance. It will not repair nerves but helps protect bones in people with CMT2O who are at higher fall risk. MDPI+1

6. Magnesium
Magnesium is involved in muscle relaxation and nerve conduction. For some people with muscle cramps, magnesium supplements can be helpful if they are deficient. Doses must be adapted to age and kidney function. Too much magnesium can cause diarrhea and, in kidney disease, dangerous high blood levels, so it must be used with medical guidance. MDPI+1

7. Acetyl-L-carnitine
Acetyl-L-carnitine supports mitochondrial energy metabolism and has been studied in some neuropathies. Research suggests it may improve nerve fiber regeneration and reduce pain in certain settings. Typical adult doses in studies are often 1–3 g/day, but its use in CMT2O is experimental and should be supervised by a specialist. MDPI+1

8. Curcumin (turmeric extract)
Curcumin has antioxidant and anti-inflammatory effects and is being researched for many chronic diseases. Some animal and small human studies in neuropathy suggest it may reduce inflammation and oxidative damage in nerves. It is usually taken with piperine or in special formulations to improve absorption. High doses can affect blood clotting and interact with medicines. MDPI+1

9. N-acetylcysteine (NAC)
NAC is a precursor of glutathione, a major antioxidant. It is used in hospitals for acetaminophen overdose and has been studied as a neuroprotective agent. By helping detoxify reactive oxygen species, it might protect nerve cells, but solid data in CMT are lacking. It can cause nausea or rare allergic reactions, so should not be used without medical supervision. MDPI+1

10. Probiotics and gut-health support
A healthy gut microbiome supports immune balance and nutrient absorption. Probiotics and high-fiber foods may help maintain gut health, which indirectly supports overall health and energy in CMT2O. Supplements vary widely in dose and strains, so diet-based approaches (yogurt, fermented foods, fiber) are usually started first. MDPI+1

---

Immunity-Booster, Regenerative and Stem-Cell-Related Drugs

Very important: At this time there are no FDA-approved stem cell or gene-editing drugs specifically for Charcot-Marie-Tooth neuropathy axonal type 2O. Options below describe experimental or general concepts that may be relevant in research or in other conditions.

1. Experimental gene therapy directed at DYNC1H1
Researchers are exploring gene therapies for various CMT types, using viral vectors or gene-editing tools to correct or silence harmful genes. For DYNC1H1-related CMT2O, work is still at preclinical or very early clinical stages. These treatments aim to repair or compensate the underlying axonal transport defect, but are only available within controlled research programs and may carry significant risks. MDPI+2ScienceDirect+2

2. Neurotrophic factor-based therapies
Neurotrophic factors (like NGF or BDNF) are proteins that support nerve survival and growth. Some experimental drugs mimic or boost these signals to protect or regenerate peripheral nerves. In animal models of CMT, enhancing neurotrophic support may improve axonal health, but translating this into safe human drugs is still under study. MDPI+1

3. Antioxidant and mitochondrial-targeted drugs
Many experimental medicines aim to reduce oxidative stress and improve mitochondrial function in nerve cells. These drugs try to protect axons from slow degeneration by improving energy supply and reducing toxic by-products. Some agents are in early-phase clinical trials for other neuropathies and might later be tested in CMT populations. MDPI+1

4. Immune-modulating drugs (only if overlapping immune disease)
CMT2O itself is genetic and not immune-mediated, so routine immune-suppressing drugs like IVIG, rituximab, or steroids are not standard. However, if a person with CMT2O also develops an immune neuropathy, doctors may use these drugs. They change how immune cells behave, reducing attack on nerves in autoimmune disease, but they have strong side effects and require careful specialist monitoring. PMC+1

5. Experimental stem cell therapies
Stem cell therapies aim to provide cells that can support or replace damaged nerve or Schwann cells. In animal studies, certain stem cells can release helpful growth factors or integrate into nerve tissue, but in humans, stem cell treatment for CMT is still experimental and not approved by regulators. Anyone considering this should only do so in approved clinical trials, not in unregulated clinics. MDPI+1

6. Supportive vaccines and general immunity boosters
Routine vaccines (like flu, COVID-19, and pneumonia vaccines) do not cure CMT2O, but they reduce the risk of serious infections that could worsen weakness and disability. Keeping vaccinations up to date and following public-health advice helps protect overall health and supports the ability to continue exercise and therapy. MDPI+1

---

Surgeries

1. Foot deformity correction (osteotomy)
In CMT2O, high arches and twisted feet (cavovarus deformity) can become very severe. Orthopaedic surgeons may cut and realign bones of the foot (osteotomy) to place the foot in a flatter, more stable position. This can reduce pain, improve shoe fit, and make walking safer and more efficient, especially when braces alone are not enough. nhs.uk+2ScienceDirect+2

2. Tendon transfer surgery
Tendon transfers move stronger, functioning tendons into positions where muscles are weak or paralyzed, such as moving a functioning tendon to help lift the foot and prevent drop. In CMT, this can balance muscle forces around the ankle and foot, reduce deformity, and allow better use of AFOs. The goal is to improve gait and reduce tripping. ScienceDirect+1

3. Joint fusion (arthrodesis)
If a joint is severely deformed and painful, surgeons may fuse it so it no longer moves, for example fusing joints in the mid-foot or hind-foot. This sacrifices flexibility but can give a stable platform for standing and walking. In advanced CMT deformities, arthrodesis can reduce chronic pain and make brace fitting easier. ScienceDirect+1

4. Spine surgery for scoliosis
Some people with DYNC1H1-related disorders develop scoliosis (curved spine). If the curve becomes large or causes breathing or sitting problems, spinal fusion surgery may be recommended. Metal rods and screws straighten and stabilize the spine, helping posture, comfort, and lung function, although it is a major operation requiring careful planning. MalaCards+2MDPI+2

5. Decompression or soft-tissue release procedures
Tight tendons and ligaments can worsen deformities and cause pain. Surgeons may lengthen the Achilles tendon or release tight soft tissues around the foot or ankle. This can increase range of motion, make brace use easier, and delay more extensive bone surgery. Decisions depend on age, severity, and walking goals. ScienceDirect+1

---

Preventions

Because CMT2O is genetic, we cannot prevent the basic cause, but we can prevent complications and faster progression:

1. Early diagnosis and regular follow-up – Seeing a neurologist early allows timely braces, therapy, and family counseling, helping prevent fixed deformities and repeated injuries. MalaCards+1

2. Daily stretching and safe exercise – Consistent, gentle activity prevents contractures, maintains strength, and keeps joints flexible. Mayo Clinic+1

3. Fall-prevention strategies – Use of AFOs, canes, good lighting, and home modifications to avoid fractures. PMC+1

4. Foot care and skin checks – Regular inspection of feet for blisters or pressure spots prevents ulcers and infections. nhs.uk+1

5. Avoiding nerve-toxic drugs – Inform all doctors about CMT2O so they can avoid medicines that worsen neuropathy. PMC+1

6. Maintaining healthy weight – Extra weight increases stress on weak feet and ankles; a balanced diet and activity help protect joints. MDPI+1

7. Safe footwear choices – Supportive, closed shoes with good grip and enough room for braces lower the risk of falls and skin damage. nhs.uk+1

8. Vaccinations and infection control – Staying up to date with vaccines reduces illness-related weakness and time away from therapy. MDPI+1

9. Mental-health support – Preventing depression and anxiety with counseling and peer groups helps people stay engaged with care. Muscular Dystrophy Association+1

10. Genetic counseling before pregnancy – Helps families understand inheritance risks and options such as prenatal or pre-implantation testing. MalaCards+1

---

When to See Doctors

You should seek medical help early and regularly when living with Charcot-Marie-Tooth neuropathy axonal type 2O. A neurologist should be consulted at diagnosis, when new weakness or balance problems appear, or when there is a big change in walking, falls, or hand use. Urgent review is needed if there is sudden rapid worsening, new severe pain, loss of bladder or bowel control, major scoliosis or breathing difficulty, or signs of infection in the feet like redness, warmth, or open sores. Periodic visits to physiotherapy, occupational therapy, and orthopaedic clinics are important to adjust braces, exercises, and shoe supports as the body grows or changes. Mental-health professionals should be involved if there is persistent low mood, anxiety, or difficulty coping with a chronic disease. Regular, team-based care helps keep symptoms under control and prevents many future complications. PMC+2Mayo Clinic+2

---

What to Eat and What to Avoid

What to eat (5 points)

1. Plenty of fruits and vegetables – Provide vitamins, antioxidants, and fiber that support general health, immune function, and energy.

2. Lean proteins – Fish, poultry, beans, lentils, and eggs support muscle repair and strength, important when muscles are weak.

3. Whole grains – Brown rice, oats, and whole-wheat breads provide steady energy and help prevent weight gain that stresses joints.

4. Healthy fats – Nuts, seeds, avocado, and olive oil supply omega-3 and other fats that may support heart and nerve health.

5. Calcium- and vitamin D–rich foods – Dairy, fortified plant milks, and some fish help keep bones strong, reducing fracture risk in falls. MDPI+1

What to avoid or limit (5 points)

1. Sugary drinks and junk food – These promote weight gain and offer little nutrition, adding extra load to weak feet and ankles.

2. Excessive alcohol – Alcohol can damage nerves and worsen balance, increasing fall risk and neuropathy.

3. Very high-salt snacks – Too much salt may worsen blood pressure and swelling in legs, making walking harder.

4. Crash diets or very low-calorie plans – These can cause muscle loss and nutrient deficiencies that worsen weakness.

5. Unregulated “miracle” supplements – Products claiming to cure CMT or regrow nerves without scientific proof can waste money and may be unsafe; always check with a doctor first. MDPI+1

---

Frequently Asked Questions (FAQs)

1. Is Charcot-Marie-Tooth neuropathy axonal type 2O curable?
No. At present there is no cure that can remove the gene change in DYNC1H1 or fully reverse nerve damage. Treatment focuses on reducing symptoms, improving function, and preventing complications through therapy, braces, medicines for pain, and sometimes surgery. Research on gene-targeted therapies is ongoing, but still experimental. MalaCards+2MDPI+2

2. Will everyone with CMT2O eventually need a wheelchair?
Not necessarily. CMT2O is usually slowly progressive, and many people remain able to walk, especially with braces, proper shoes, and therapy. Some may use a wheelchair or scooter for long distances or later in life. The course can vary even within the same family. MalaCards+2MDPI+2

3. Can exercise make my nerves worse?
Gentle, well-planned exercise is helpful and does not damage nerves; it keeps muscles and joints as strong and flexible as possible. Very intense, heavy-load, or high-impact exercise may strain weak muscles and joints, so programs should be designed by a physiotherapist who understands CMT. PMC+2Journal of Health and Allied Sciences NU+2

4. Why is physical therapy so important if the disease is genetic?
Therapy cannot change genes, but it can greatly slow the development of contractures, weakness-related disability, and imbalance. This means people often stay independent longer, with better walking and hand function, even though the underlying cause remains. Mayo Clinic+2nhs.uk+2

5. Are the pain medicines addictive?
Most neuropathic pain medicines like gabapentin, pregabalin, and duloxetine are not classic opioids but can still cause dependence or withdrawal if stopped suddenly. Opioid-like medicines such as tramadol have a higher addiction risk. Doctors try to use the lowest effective doses and monitor for side effects and misuse. FDA Access Data+3FDA Access Data+3FDA Access Data+3

6. Can children take these medicines?
Some medicines have pediatric dosing information, while others are not recommended for children. For example, tramadol has serious warnings in people under 18. A pediatric neurologist or pain specialist must decide which medicines are safe, and doses must be carefully calculated by age and weight. FDA Access Data+2FDA Access Data+2

7. Will surgery fix my CMT2O permanently?
Surgery can correct deformities and improve function but does not change the underlying nerve disease. Over time, further weakness or new deformities may appear. However, many people experience long-lasting benefits in pain relief and walking ability after well-planned orthopaedic surgery. ScienceDirect+2nhs.uk+2

8. Can diet alone treat CMT2O?
Diet cannot cure or halt the genetic process of CMT2O, but a healthy diet supports weight control, bone strength, and general energy. Good nutrition makes it easier to stay active, attend therapy, and recover from surgery or illness, all of which affect quality of life. MDPI+1

9. Should I get genetic testing?
Genetic testing can confirm the diagnosis, identify the specific DYNC1H1 variant, and help with family planning. It can also help doctors include you in appropriate research or trials. A genetic counselor can explain the benefits, limits, and emotional impact of testing before you decide. NCBI+2MalaCards+2

10. Can CMT2O affect thinking or learning?
Most people with CMT2O primarily have peripheral nerve problems, but DYNC1H1-related disorders can sometimes include brain involvement, such as intellectual disability or epilepsy, depending on the exact mutation. A neurologist will look for these features and arrange brain imaging or developmental assessments when needed. NCBI+2MalaCards+2

11. Is pregnancy safe in someone with CMT2O?
Many people with CMT have successful pregnancies. However, pregnancy can sometimes worsen weakness or balance issues, and special care may be needed for delivery and anesthesia. Genetic counseling before pregnancy helps parents understand the 50% inheritance risk and available reproductive options. PMC+2MalaCards+2

12. How often should I see my neurologist?
Frequency depends on disease severity and change over time. Many patients are reviewed yearly, but more frequent visits may be needed if symptoms are progressing quickly, new problems appear, or treatments are being changed. Regular follow-up ensures braces, medicines, and therapies are up to date. PMC+1

13. Are there special precautions for anesthesia or surgery?
Yes. Weak muscles, foot deformities, or possible spine curvature may require special positioning and careful choice of anesthetic drugs. It is important to tell the anesthesiologist about the CMT2O diagnosis and provide genetic or neurology reports if available. PMC+1

14. Can CMT2O get better on its own?
CMT2O is usually slowly progressive rather than improving, but symptoms can be much better controlled with good care. People often notice large functional gains after starting physiotherapy, getting braces, or having corrective surgery, even though the basic disease is still present. MalaCards+2PMC+2

15. Where can I find more support and information?
National neuromuscular organizations, CMT patient associations, and rare-disease networks provide education, support groups, and updates on research. Many publish free guides for physical and occupational therapy and help connect families with specialist clinics and clinical trials. Muscular Dystrophy Association+2cmtausa.org+2

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 22, 2025.